[1]
|
温韬, 赵金垣. 中毒性肝损伤发病机制的研究动态[J]. 中国工业医学杂志, 2009, 22(6): 434-438.
|
[2]
|
Frenzel, C. and Teschke, R. (2016) Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation. International Journal of Molecular Sciences, 17, Article 588. https://doi.org/10.3390/ijms17050588
|
[3]
|
Garcia-Cortes, M., Robles-Diaz, M., Stephens, C., Ortega-Alonso, A., Lucena, M.I. and Andrade, R.J. (2020) Drug Induced Liver Injury: An Update. Archives of Toxicology, 94, 3381-3407. https://doi.org/10.1007/s00204-020-02885-1
|
[4]
|
Li, J., Guo, C. and Wu, J. (2020) Astaxanthin in Liver Health and Disease: A Potential Therapeutic Agent. Drug Design, Development and Therapy, 14, 2275-2285. https://doi.org/10.2147/dddt.s230749
|
[5]
|
胡艺琪, 史瑞雅, 陈佳音, 等. 虾青素临床研究现状及其在特医食品开发中的应用前景[J]. 中国海洋药物, 2022, 41(4): 89-94.
|
[6]
|
余小元, 谢子健, 曹月琴, 等. 虾青素的主要来源物种——雨生红球藻[J]. 生物学通报, 2022, 57(2): 7-11.
|
[7]
|
Lorenz, R.T. and Cysewski, G.R. (2000) Commercial Potential for Haematococcus Microalgae as a Natural Source of Astaxanthin. Trends in Biotechnology, 18, 160-167. https://doi.org/10.1016/s0167-7799(00)01433-5
|
[8]
|
Stachowiak, B. and Szulc, P. (2021) Astaxanthin for the Food Industry. Molecules, 26, Article 2666. https://doi.org/10.3390/molecules26092666
|
[9]
|
Naguib, Y.M.A. (2000) Antioxidant Activities of Astaxanthin and Related Carotenoids. Journal of Agricultural and Food Chemistry, 48, 1150-1154. https://doi.org/10.1021/jf991106k
|
[10]
|
Kohandel, Z., Farkhondeh, T., Aschner, M., Pourbagher-Shahri, A.M. and Samarghandian, S. (2022) Anti-Inflammatory Action of Astaxanthin and Its Use in the Treatment of Various Diseases. Biomedicine & Pharmacotherapy, 145, Article ID: 112179. https://doi.org/10.1016/j.biopha.2021.112179
|
[11]
|
Nakagawa, K., Kiko, T., Miyazawa, T., Carpentero Burdeos, G., Kimura, F., Satoh, A., et al. (2011) Antioxidant Effect of Astaxanthin on Phospholipid Peroxidation in Human Erythrocytes. British Journal of Nutrition, 105, 1563-1571. https://doi.org/10.1017/s0007114510005398
|
[12]
|
陆婵君, 郭艺, 胡可, 等. 虾青素调控Nrf2通路发挥心血管保护作用的研究进展[J]. 中国新药与临床杂志, 2023, 42(5): 284-288.
|
[13]
|
Li, H., Li, J., Hou, C., Li, J., Peng, H. and Wang, Q. (2020) The Effect of Astaxanthin on Inflammation in Hyperosmolarity of Experimental Dry Eye Model in Vitro and in Vivo. Experimental Eye Research, 197, Article ID: 108113. https://doi.org/10.1016/j.exer.2020.108113
|
[14]
|
Cui, L., Xu, F., Wang, M., Li, L., Qiao, T., Cui, H., et al. (2019) Dietary Natural Astaxanthin at an Early Stage Inhibits N-Nitrosomethylbenzylamine-Induced Esophageal Cancer Oxidative Stress and Inflammation via Downregulation of NFκB and COX2 in F344 Rats. OncoTargets and Therapy, 12, 5087-5096. https://doi.org/10.2147/ott.s197044
|
[15]
|
中华医学会, 中华医学会杂志社, 中华医学会消化病学分会, 中华医学会全科医学分会, 中华医学会《中华全科医师杂志》编辑委员会, 消化系统疾病基层诊疗指南编写专家组. 药物性肝损伤基层诊疗指南(2019年) [J].中华全科医师杂志, 2020, 19(10): 868-875.
|
[16]
|
章晨怡, 茹清静. 浅议“药毒”与药物性肝损伤[J]. 中西医结合肝病杂志, 2020, 30(2): 179-181.
|
[17]
|
朱蓉蓉, 谢治强, 马瑞萍. 药物性肝损伤研究现状[J]. 社区医学杂志, 2023, 21(10): 535-539.
|
[18]
|
卢伟, 潘梦, 方亦可, 等. 中药治疗急性肝损伤作用机制研究进展[J]. 中南药学, 2019, 17(9): 1504-1507.
|
[19]
|
Stravitz, R.T. and Lee, W.M. (2019) Acute Liver Failure. The Lancet, 394, 869-881. https://doi.org/10.1016/s0140-6736(19)31894-x
|
[20]
|
Moles, A., Torres, S., Baulies, A., Garcia-Ruiz, C. and Fernandez-Checa, J.C. (2018) Mitochondrial-Lysosomal Axis in Acetaminophen Hepatotoxicity. Frontiers in Pharmacology, 9, Article 453. https://doi.org/10.3389/fphar.2018.00453
|
[21]
|
da Rocha, B.A., Ritter, A.M.V., Ames, F.Q., Gonçalves, O.H., Leimann, F.V., Bracht, L., et al. (2017) Acetaminophen-induced Hepatotoxicity: Preventive Effect of Trans Anethole. Biomedicine & Pharmacotherapy, 86, 213-220. https://doi.org/10.1016/j.biopha.2016.12.014
|
[22]
|
Yan, M., Huo, Y., Yin, S. and Hu, H. (2018) Mechanisms of Acetaminophen-Induced Liver Injury and Its Implications for Therapeutic Interventions. Redox Biology, 17, 274-283. https://doi.org/10.1016/j.redox.2018.04.019
|
[23]
|
Jaeschke, H., Akakpo, J.Y., Umbaugh, D.S. and Ramachandran, A. (2020) Novel Therapeutic Approaches against Acetaminophen-Induced Liver Injury and Acute Liver Failure. Toxicological Sciences, 174, 159-167. https://doi.org/10.1093/toxsci/kfaa002
|
[24]
|
Cai, X., Hua, S., Deng, J., Du, Z., Zhang, D., Liu, Z., et al. (2022) Astaxanthin Activated the Nrf2/HO-1 Pathway to Enhance Autophagy and Inhibit Ferroptosis, Ameliorating Acetaminophen-Induced Liver Injury. ACS Applied Materials & Interfaces, 14, 42887-42903. https://doi.org/10.1021/acsami.2c10506
|
[25]
|
Mohan, M., Kamble, S., Gadhi, P. and Kasture, S. (2010) Protective Effect of Solanum Torvum on Doxorubicin-Induced Nephrotoxicity in Rats. Food and Chemical Toxicology, 48, 436-440. https://doi.org/10.1016/j.fct.2009.10.042
|
[26]
|
Ma, H., Chen, S., Xiong, H., Wang, M., Hang, W., Zhu, X., et al. (2020) Astaxanthin from Haematococcus pluvialis Ameliorates the Chemotherapeutic Drug (Doxorubicin) Induced Liver Injury through the Keap1/Nrf2/HO-1 Pathway in Mice. Food & Function, 11, 4659-4671. https://doi.org/10.1039/c9fo02429h
|
[27]
|
Belfayol-Pisanté, L., Guillevin, L., Tod, M. and Fauvelle, F. (2000) Pharmacokinetics of Cyclophosphamide (CP) and 4-OH-CP/aldophosphamide in Systemic Vasculitis. Fundamental & Clinical Pharmacology, 14, 415-421. https://doi.org/10.1111/j.1472-8206.2000.tb00424.x
|
[28]
|
Zhong, S., Huang, M., Yang, X., Liang, L., Wang, Y., Romkes, M., et al. (2006) Relationship of Glutathione S-Transferase Genotypes with Side-effects of Pulsed Cyclophosphamide Therapy in Patients with Systemic Lupus Erythematosus. British Journal of Clinical Pharmacology, 62, 457-472. https://doi.org/10.1111/j.1365-2125.2006.02690.x
|
[29]
|
Tripathi, D.N. and Jena, G.B. (2010) Astaxanthin Intervention Ameliorates Cyclophosphamide-Induced Oxidative Stress, DNA Damage and Early Hepatocarcinogenesis in Rat: Role of Nrf2, P53, P38 and Phase-Ii Enzymes. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 696, 69-80. https://doi.org/10.1016/j.mrgentox.2009.12.014
|
[30]
|
邓亮, 徐可树. 中毒性肝病诊治的相关问题[J]. 中国临床医生, 2014, 42(10): 14-17.
|
[31]
|
Ohta, Y., Kongo-Nishimura, M., Matsura, T., Yamada, K., Kitagawa, A. and Kishikawa, T. (2003) Melatonin Prevents Disruption of Hepatic Reactive Oxygen Species Metabolism in Rats Treated with Carbon Tetrachloride. Journal of Pineal Research, 36, 10-17. https://doi.org/10.1046/j.1600-079x.2003.00091.x
|
[32]
|
Zhang, C., Han, C., Zhao, B. and Yu, H. (2012) The Protective Effects of Aqueous Extracts of Wild-Growing and Fermented Royal Sun Mushroom, Agaricus brasiliensis S. Wasser et al. (Higher Basidiomycetes), in CCl4-Induced Oxidative Damage in Rats. International Journal of Medicinal Mushrooms, 14, 557-561. https://doi.org/10.1615/intjmedmushr.v14.i6.30
|
[33]
|
Ohta, Y., Imai, Y., Matsura, T., Kitagawa, A. and Yamada, K. (2006) Preventive Effect of Neutropenia on Carbon Tetrachloride-Induced Hepatotoxicity in Rats. Journal of Applied Toxicology, 26, 178-186. https://doi.org/10.1002/jat.1122
|
[34]
|
Kang, J.O., Kim, S.J. and Kim, H. (2001) Effect of Astaxanthin on the Hepatotoxicity, Lipid Peroxidation and Antioxidative Enzymes in the Liver of CCl4-Treated Rats. Methods and Findings in Experimental and Clinical Pharmacology, 23, 79. https://doi.org/10.1358/mf.2001.23.2.627931
|
[35]
|
Alam, M.A., Islam, M.A., Al Mamun, M.A., Faruk, M., Ul Islam, M.T., Rahman, M.M., et al. (2017) Astaxanthin Ameliorates Hepatic Damage and Oxidative Stress in Carbon Tetrachloride-Administered Rats. Pharmacognosy Research, 9, s84-s91. https://doi.org/10.4103/pr.pr_26_17
|
[36]
|
Lee, J.Y. and Hwang, D.H. (2006) The Modulation of Inflammatory Gene Expression by Lipids: Mediation through Toll-Like Receptors. Molecules and Cells, 21, 174-185. https://doi.org/10.1016/s1016-8478(23)12877-9
|
[37]
|
Du, L., Zheng, Y., Yang, Y., Huang, Y., Hao, Y., Chen, C., et al. (2022) Krill Oil Prevents Lipopolysaccharide-Evoked Acute Liver Injury in Mice through Inhibition of Oxidative Stress and Inflammation. Food & Function, 13, 3853-3864. https://doi.org/10.1039/d1fo04136c
|
[38]
|
Zhang, Z., Guo, C., Jiang, H., Han, B., Wang, X., Li, S., et al. (2020) Inflammation Response after the Cessation of Chronic Arsenic Exposure and Post-Treatment of Natural Astaxanthin in Liver: Potential Role of Cytokine-Mediated Cell-Cell Interactions. Food & Function, 11, 9252-9262. https://doi.org/10.1039/d0fo01223h
|
[39]
|
陈金丽. 虾青素对牛黄解毒片所致小鼠肝脏损伤的保护作用及其可能机制[D]: [硕士学位论文]. 沈阳: 中国医科大学, 2018.
|
[40]
|
Xu, L., Xu, X., Guo, L., Wang, Z., Wu, X., Kuang, H., et al. (2021) Potential Environmental Health Risk Analysis of Neonicotinoids and a Synergist. Environmental Science & Technology, 55, 7541-7550. https://doi.org/10.1021/acs.est.1c00872
|
[41]
|
Sarιkaya, R., Sepici-Dinçel, A., Çaǧlan Karasu Benli, A., Selvi, M. and Erkoç, F. (2010) The Acute Toxicity of Fenitrothion on Narrow-Clawed Crayfish (Astacus leptodactylus Eschscholtz, 1823) in Association with Biomarkers of Lipid Peroxidation. Journal of Biochemical and Molecular Toxicology, 25, 169-174. https://doi.org/10.1002/jbt.20373
|
[42]
|
Abou-Zeid, S.M., Aljuaydi, S.H., AbuBakr, H.O., Tahoun, E.A., Di Cerbo, A., Alagawany, M., et al. (2021) Astaxanthin Mitigates Thiacloprid-Induced Liver Injury and Immunotoxicity in Male Rats. Marine Drugs, 19, Article 525. https://doi.org/10.3390/md19090525
|
[43]
|
Gradelet, S., Astorg, P., Le Bon, A., Bergès, R. and Suschetet, M. (1997) Modulation of Aflatoxin B1 Carcinogenicity, Genotoxicity and Metabolism in Rat Liver by Dietary Carotenoids: Evidence for a Protective Effect of CYP1A Inducers. Cancer Letters, 114, 221-223. https://doi.org/10.1016/s0304-3835(97)04668-5
|
[44]
|
Monmeesil, P., Fungfuang, W., Tulayakul, P. and Pongchairerk, U. (2019) The Effects of Astaxanthin on Liver Histopathology and Expression of Superoxide Dismutase in Rat Aflatoxicosis. Journal of Veterinary Medical Science, 81, 1162-1172. https://doi.org/10.1292/jvms.18-0690
|
[45]
|
Tian, Y., Che, H., Yang, J., Jin, Y., Yu, H., Wang, C., et al. (2023) Astaxanthin Alleviates Aflatoxin B1-Induced Oxidative Stress and Apoptosis in IPEC-J2 Cells via the Nrf2 Signaling Pathway. Toxins, 15, Article 232. https://doi.org/10.3390/toxins15030232
|
[46]
|
Jaurigue, M.M. (2014) Therapy for Alcoholic Liver Disease. World Journal of Gastroenterology, 20, 2143-2158. https://doi.org/10.3748/wjg.v20.i9.2143
|
[47]
|
Hosseini, N., Shor, J. and Szabo, G. (2019) Alcoholic Hepatitis: A Review. Alcohol and Alcoholism, 54, 408-416. https://doi.org/10.1093/alcalc/agz036
|
[48]
|
Dunn, W. and Shah, V.H. (2016) Pathogenesis of Alcoholic Liver Disease. Clinics in Liver Disease, 20, 445-456. https://doi.org/10.1016/j.cld.2016.02.004
|
[49]
|
Yan, J., Nie, Y., Luo, M., Chen, Z. and He, B. (2021) Natural Compounds: A Potential Treatment for Alcoholic Liver Disease? Frontiers in Pharmacology, 12, Article 694475. https://doi.org/10.3389/fphar.2021.694475
|
[50]
|
Liu, H., Liu, M., Fu, X., Zhang, Z., Zhu, L., Zheng, X., et al. (2018) Astaxanthin Prevents Alcoholic Fatty Liver Disease by Modulating Mouse Gut Microbiota. Nutrients, 10, Article 1298. https://doi.org/10.3390/nu10091298
|